2m 2m 2m 2m 2m 2m 2m
Bioline RX Sp ADR (BLRX)
NASDAQ
$3.10-$0.004 (-0.13%)
Price as of Jul 13, 2026 7:54 PM EDT- $13.4MMarket Cap
- -34.04%1-Year Change
- BiotechnologyIndustry
Bioline RX Sp ADR (BLRX)
$3.10-$0.004 (-0.13%)
BLRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.10 | ||
Change | +$0.01 (+0.32%) | ||
Open | $3.18 | ||
High | $3.18 | ||
Low | $2.98 | ||
Previous Close | $3.09 | ||
Volume | 12,600 | ||
30-Day Average Volume | 26,692 | ||
1-Week Change | -1.81% | ||
1-Month Change | -8.01% | ||
1-Year Change | -34.04% | ||
3-Year Change | -95.41% | ||
5-Year Change | -97.35% | ||
Fundamentals | |||
Shares Outstanding | 4.4M | ||
Total Assets | $40.9M | ||
Market Cap | $13.4M | ||
Enterprise Value | $10.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 01/30/2025 | ||
Earnings & Revenue